Coral Laboratories share news and announcements
BSE: 524506Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹506.95.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹177 Cr2,551st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 20 Oct 2026
- 9.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 Sep 2026
- 0.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.40%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 20 Oct 2026
- 9.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 20 Oct 2026
- 7.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 Sep 2026
- 0.02
- Volume, BSEVolume. Shares traded on the last trading day.
- 2,855
Coral Laboratories share news and announcements
720 announcements, routine notices left out, newest first. Page 11 of 15.
Apr 2017
17 Apr · Compliance Certificate For The Half Year Ended 31St March, 2017
13 Apr · Compliance Certificate From PCS Under Reg 40(9) And 40(10) Of SEBI ( Listing Obligations And Disclosure Requirements), Regulations 2015 For The Half Year Ended 31St March, 2017
11 Apr · Statement Of Status Of Investor Complaints For The Quarter And Year Ended 31St March, 2017.
7 Apr · Disclosure Under Regulation 32(1) Of SEBI( Listing Obligations And Disclosure Requirements)Regulations, 2015
Jan 2017
18 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
17 Jan · Shareholding for the Period Ended December 31, 2016
Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....
Nov 2016
Oct 2016
25 Oct · Management
16 Oct · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
15 Oct · Shareholding for the Period Ended September 30, 2016
Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click ....
Sep 2016
Aug 2016
Jul 2016
21 Jul · Shareholding for the Period Ended June 30, 2016
Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click ....21 Jul · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
May 2016
30 May · Dividend
Board of Directors of the Company at its meeting held on May 30, 2016, inter alia, has proposed dividend @ 30% i.e. Rs. 3 per Equity share ....20 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 30, 2016, for considering and adopting Audited Financial Results for ....
Apr 2016
18 Apr · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
14 Apr · Shareholding for the Period Ended March 31, 2016
Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click ....
Feb 2016
10 Feb · Shareholding for the Period Ended December 31, 2015
Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click ....
Jan 2016
21 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Dec 2015
29 Dec · Authorised KMPs to determine materiality of events/information
Nov 2015
4 Nov · Revised Shareholding Pattern For September 30, 2015
Oct 2015
22 Oct · Shareholding Pattern for September 30, 2015
Sep 2015
Aug 2015
Jul 2015
31 Jul · Limited Review for June 30, 2015
30 Jul · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from September 10, 2015 to September 16, 2015 (both days inclusive) ....23 Jul · Shareholding Pattern For June 30, 2015
Jun 2015
1 Jun · Code of Conduct of Fair Disclosure
May 2015
15 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 29, 2015, to conduct the following business: 1. To consider and ....
Apr 2015
29 Apr · Shareholding Pattern For March 31, 2015